Reducing the impact of lead exposure
The annual economic cost of pediatric lead poisoning is $43 billion. Other childhood diseases with environmental causes, such as asthma and childhood cancer, are $2.0 and $0.3 billion, respectively.1
It is estimated that over 535,000 children in the U.S. have harmful blood lead levels.2
The American Academy of Pediatrics (AAP) recommends that managed care organizations fully cover the costs of lead screening and follow-up.3
Improve HEDIS scores. Blood lead testing became a permanent HEDIS measure in 2009. The National Committee for Quality Assurance (NCQA) reminds, “High blood lead levels have significant health implications that are often irreversible in children and lead to unnecessary medical expenses.”4
Organizations that have implemented on-site lead testing have seen dramatic improvement in compliance with mandated testing.
Elevated blood lead levels have been associated with avoidable medical costs of $1,300 per child.5 Early intervention may save on expensive treatments later.
To learn more about using the LeadCare II system to improve compliance, contact us.